RESEARCH PROTOCOLS

Once Centimeter Non-small Cell Lung Cancer: Clinical Correlates (IRB approved 4/2004 to 5/2006)
Principal Investigator-New York Presbyterian Hospital, Weill Medical College of Cornell University

Phase II, Non-randomized, Multicenter Study to Evaluate the Safety and Efficacy of Pazopanib (GW786034) as Pre-Surgical Therapy in Treatment-Naive Subjects with Stage IA or IB, Resectable Non Small Cell Lung Cancer (NSCLC) (IRB approved 7/2006)
Site Principal Investigator-New York Hospital Queens